Efficacy and Safety of Long-Term Administration of Dapagliflozin for Japanese Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Yamazaki, Masahiro
Sakai, Ryosuke
Okamura, Takuro
Fukui, Michiaki
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1180-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus
    Liakos, Aris
    Karagiannis, Thomas
    Bekiari, Eleni
    Boura, Panagiota
    Tsapas, Apostolos
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (02) : 61 - 67
  • [2] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    DIABETES, 2012, 61 : A260 - A260
  • [3] Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Kaku, Kohei
    Kondo, Kazuoki
    Maruyama, Nobuko
    Otsuka, Makiko
    Kawaguchi, Yutaka
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 812 - 820
  • [4] Long-Term Safety, Tolerability and Efficacy of Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus: IGNITE
    Kawano, Hiromichi
    Kashiwagi, Atsunori
    Kazuta, Kenichi
    Yoshida, Satoshi
    Ueyama, Eiji
    Utsuno, Atsushi
    DIABETES, 2012, 61 : A610 - A610
  • [5] Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease
    Leiter, L. A.
    Cefalu, W. T.
    de Bruin, T. W. A.
    Xu, J.
    Parikh, S.
    Johnsson, E.
    Gause-Nilsson, I.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 766 - 774
  • [6] Long-term Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes, Cardiovascular Disease, and Hypertension
    Cefalu, William T.
    Gause-Nilsson, Ingrid Ami
    De Bruin, Tjerk W. A.
    Sugg, Jennifer E.
    Parikh, Shamik J.
    Johnsson, Eva
    DIABETES, 2014, 63 : A286 - A286
  • [7] Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus
    Tada, Yuko
    Kanazawa, Ippei
    Notsu, Masakazu
    Tanaka, Ken-ichiro
    Kiyohara, Nobuaki
    Sasaki, Motofumi
    Sugimoto, Toshitsugu
    INTERNAL MEDICINE, 2016, 55 (10) : 1275 - 1278
  • [8] Safety and efficacy of Dapagliflozin type 2 diabetes mellitus patients during fasting
    Fatima, N.
    Baloch, A. Ali
    Kiran, Z.
    Shabbir, K. U.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [9] Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin A Randomized Trial
    Wilding, John P. H.
    Woo, Vincent
    Soler, Norman G.
    Pahor, Andrea
    Sugg, Jennifer
    Rohwedder, Katja
    Parikh, Shamik
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (06) : 405 - U50
  • [10] Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial
    Wilding, J. P. H.
    Woo, V.
    Soler, N. G.
    Pahor, A.
    Sugg, J.
    Rohwedder, K.
    Parikh, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 : S27 - S38
12345